BIRC5 and breast cancer: Moreover, BIRC5 was expressed significantly higher in triple-negative breast cancer, a type of breast cancer known to be more aggressive and with poor prognosis, compared to all other combined subtypes (Fig. 1C, p = 3.5e-8).